Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-

被引：0

作者：

Kosuke Ebina

Toru Hirano

Yuichi Maeda

Wataru Yamamoto

Motomu Hashimoto

Koichi Murata

Tohru Takeuchi

Koji Nagai

Yonsu Son

Hideki Amuro

Akira Onishi

Sadao Jinno

Ryota Hara

Masaki Katayama

Keiichi Yamamoto

Atsushi Kumanogoh

Makoto Hirao

机构：

[1] Osaka University,Department of Musculoskeletal Regenerative Medicine, Graduate School of Medicine

[2] Osaka University,Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine

[3] Kurashiki Sweet Hospital,Department of Health Information Management

[4] Kyoto University,Department of Advanced Medicine for Rheumatic diseases, Graduate School of Medicine

[5] Osaka Medical College,Department of Internal Medicine (IV)

[6] Koshokai Aino Hospital,Rheumatology center

[7] Kansai Medical University,First Department of Internal Medicine

[8] Kobe University Graduate School of Medicine,Department of Rheumatology and Clinical Immunology

[9] Nara Medical University,The Center for Rheumatic Diseases

[10] Osaka Red Cross Hospital,Department of Rheumatology

[11] Wakayama Medical University Hospital,Department of Medical Informatics

[12] Osaka University,Department of Orthopaedic Surgery, Graduate School of Medicine

来源：

Clinical Rheumatology | 2020年 / 39卷

关键词：

Abatacept; Biologics; Drug retention; Janus kinase inhibitors; Rheumatoid arthritis; Tocilizumab;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2563 / 2572

页数：9

共 50 条

[1] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study [J].

Ebina, Kosuke ;

Hirano, Toru ;

Maeda, Yuichi ;

Yamamoto, Wataru ;

Hashimoto, Motomu ;

Murata, Koichi ;

Takeuchi, Tohru ;

Nagai, Koji ;

Son, Yonsu ;

Amuro, Hideki ;

Onishi, Akira ;

Jinno, Sadao ;

Hara, Ryota ;

Katayama, Masaki ;

Yamamoto, Keiichi ;

Kumanogoh, Atsushi ;

Hirao, Makoto .

CLINICAL RHEUMATOLOGY, 2020, 39 (09) :2563-2572

[2] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY [J].

Ebina, K. ;

Etani, Y. ;

Maeda, Y. ;

Okita, Y. ;

Hirao, M. ;

Yamamoto, W. ;

Hashimoto, M. ;

Murata, K. ;

Hara, R. ;

Nagai, K. ;

Hiramatsu, Y. ;

Son, Y. ;

Amuro, H. ;

Fujii, T. ;

Okano, T. ;

Ueda, Y. ;

Katayama, M. ;

Okano, T. ;

Kumanogoh, A. ;

Okada, S. ;

Nakata, K. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :234-235

[3] Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study [J].

Ebina, Kosuke ;

Etani, Yuki ;

Maeda, Yuichi ;

Okita, Yasutaka ;

Hirao, Makoto ;

Yamamoto, Wataru ;

Hashimoto, Motomu ;

Murata, Koichi ;

Hara, Ryota ;

Nagai, Koji ;

Hiramatsu, Yuri ;

Son, Yonsu ;

Amuro, Hideki ;

Fujii, Takayuki ;

Okano, Takaichi ;

Ueda, Yo ;

Katayama, Masaki ;

Okano, Tadashi ;

Tachibana, Shotaro ;

Hayashi, Shinya ;

Kumanogoh, Atsushi ;

Okada, Seiji ;

Nakata, Ken .

RMD OPEN, 2023, 9 (03)

[4] Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study- [J].

Ebina, Kosuke ;

Hashimoto, Motomu ;

Yamamoto, Wataru ;

Ohnishi, Akira ;

Kabata, Daijiro ;

Hirano, Toru ;

Hara, Ryota ;

Katayame, Masaki ;

Yoshida, Shuzo ;

Nagai, Koji ;

Son, Yonsu ;

Amuro, Hideki ;

Akashi, Kengo ;

Fujimura, Takanori ;

Hirao, Makoto ;

Yamamoto, Keiichi ;

Shintani, Ayumi ;

Kumanogoh, Atsushi ;

Yoshikawa, Hideki .

PLOS ONE, 2018, 13 (03)

[5] Drug retention of 7 biologics and tofacitinib in biologics-naive and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study [J].

Ebina, Kosuke ;

Hirano, Toru ;

Maeda, Yuichi ;

Yamamoto, Wataru ;

Hashimoto, Motomu ;

Murata, Koichi ;

Takeuchi, Tohru ;

Shiba, Hideyuki ;

Son, Yonsu ;

Amuro, Hideki ;

Onishi, Akira ;

Akashi, Kengo ;

Hara, Ryota ;

Katayama, Masaki ;

Yamamoto, Keiichi ;

Kumanogoh, Atsushi ;

Hirao, Makoto .

ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)

[6] IMPACT OF SEROPOSITIVITY ON DRUG RETENTION OF BIOLOGICS AND JAK INHIBITORS -THE ANSWER COHORT STUDY [J].

Etani, Y. ;

Ebina, K. ;

Okita, Y. ;

Maeda, Y. ;

Tsujimoto, K. ;

Onishi, A. ;

Onizawa, H. ;

Okano, T. ;

Nishimura, K. ;

Yoshikawa, A. ;

Shiba, H. ;

Amuro, H. ;

Son, Y. ;

Hashimoto, M. ;

Okano, T. ;

Hara, R. ;

Yamamoto, W. ;

Kumanogoh, A. ;

Okada, S. .

ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1389-1389

[7] Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study [J].

Kosuke Ebina ;

Toru Hirano ;

Yuichi Maeda ;

Wataru Yamamoto ;

Motomu Hashimoto ;

Koichi Murata ;

Tohru Takeuchi ;

Hideyuki Shiba ;

Yonsu Son ;

Hideki Amuro ;

Akira Onishi ;

Kengo Akashi ;

Ryota Hara ;

Masaki Katayama ;

Keiichi Yamamoto ;

Atsushi Kumanogoh ;

Makoto Hirao .

Arthritis Research & Therapy, 22

[8] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis [J].

Eun Ha Kang ;

Katherine P. Liao ;

Seoyoung C. Kim .

Current Rheumatology Reports, 2018, 20

[9] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis [J].

Kang, Eun Ha ;

Liao, Katherine P. ;

Kim, Seoyoung C. .

CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)

[10] Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study [J].

Jinno, Sadao ;

Onishi, Akira ;

Hattori, Shuhei ;

Dubreuil, Maureen ;

Ueda, Yo ;

Nishimura, Keisuke ;

Okano, Takaichi ;

Yamada, Hirotaka ;

Yamamoto, Wataru ;

Murata, Koichi ;

Onizawa, Hideo ;

Ebina, Kosuke ;

Maeda, Yuichi ;

Son, Yonsu ;

Amuro, Hideki ;

Hara, Ryota ;

Hata, Kenichiro ;

Shiba, Hideyuki ;

Katayama, Masaki ;

Watanabe, Ryu ;

Hashimoto, Motomu ;

Saegusa, Jun .

RHEUMATOLOGY, 2024, 64 (02) :509-516

← 1 2 3 4 5 →